
Sign up to save your podcasts
Or
In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!
4.5
2828 ratings
In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!
26 Listeners
493 Listeners
185 Listeners
3 Listeners
7,910 Listeners
755 Listeners
12 Listeners
51 Listeners
52 Listeners
133 Listeners
1 Listeners
169 Listeners
48 Listeners
39 Listeners
3 Listeners